Additionally, glycopolymer-based nanocarriers mediated by ASGR1 have been designed to precisely deliver suicide gene therapies in combination with chemotherapeutic drugs, effectively inhibiting liver cancer cell growth and showing promising clinical potential (122). Here, ASGR1 is linked to liver cancer.